Simple triple-label detection of seven cystic fibrosis mutations by using time-resolved fluorometry

Clinical Chemistry

Volumn 43, Issue 7, 1997, Pages 1142-1150

  Heinonen, Pia ^a   Iitiä, Antti ^a,b   Torresani, Toni ^c   Lövgren, Timo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Innotrac Diagnostics Oy   (Finland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Allele specific hybridization; Genetic disease; Hybridization assay; Lanthanide chelate; PCR

Indexed keywords

CHELATE; DNA; EUROPIUM; LANTHANIDE; SAMARIUM; TERBIUM;

ARTICLE; BLOOD SAMPLING; CHILD; CYSTIC FIBROSIS; DNA HYBRIDIZATION; DNA PROBE; FLUOROMETRY; GENE AMPLIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; ISOTOPE LABELING; LABORATORY AUTOMATION; OLIGONUCLEOTIDE PROBE; PARENT; SIBLING; SIGNAL NOISE RATIO;

EID: 0030790257     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.7.1142     Document Type: Article

References (27)

1. Rommens JM, Iannuzzi MC, Kemer BS, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-64.
2. Riordan JR, Rommens JM, Kemer BS, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245: 1066-73.
3. Kemer BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
4. Tsui LC. The spectrum of cystic fibrosis mutations. Trends Genet 1992;8:392-8.
5. Ranieri E, Ryall RG, Morris CP, Nelson PV, Carey WF, Pollard AC, Robertson EF. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. Br Med J 1991;302:1237-40.
6. Lucotte G, Hazout S, De Braekeleer M. Complete map of cystic fibrosis mutation ΔF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease. Hum Biol 1995;67:797-803.
7. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
8. Dahlén PO, Iitiä AJ, Skagius G, Frostell A, Nunn MF, Kwiatkowski M. Detection of human immunodeficiency virus type 1 by using the polymerase chain reaction and a time-resolved fluorescence-based hybridization assay. J Clin Microbiol 1991;29:798-804.
9. Skogerboe KJ, West SF, Murillo MD, Tait JF. Development and evaluation of a simplified dot-blot method for detecting the ΔF508 mutation in cystic fibrosis. Clin Chem 1990;36:1984-6.
10. Landegren U, Kaiser R, Sanders J, Hood L A ligase-mediated gene detection technique. Science 1988;241:1077-80.
11. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-15.
12. Soini E, Kojola H. Time-resolved fluorometer for lanthanide chelates - a new generation of nonisotopic immunoassays. Clin Chem 1983;29:65-8.
13. Soini E, Lövgren T. Time-resolved fluorescence of lanthanide probes and applications in biotechnology. Crit Rev Anal Chem 1987;18:105-54.
14. Gudgin Dickson EF, Pollak A, Diamandis EP. Ultrasensitive bioanalytical assays using time-resoived fluorescence detection. Pharmacol Ther 1995;66:207-35.
15. Iitiä A, Høgdall E, Dahién P, Hurskainen P, Vuust J, Siitari H. Detection of mutation ΔF508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. PCR Methods Appl 1992;2:157-62.
16. 3+)-labelled oligo DNA hybridization probes. Nucleosides Nucleotides 1988;7:655-9.
17. Takalo H, Mukkala V-M, Mikola H, Liitti P, Hemmilä I. Synthesis of europium(III) chelates suitable for labeling of bioactive molecules. Bioconjugate Chem 1994;5:278-82.
18. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CL, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:2649-80.
19. Wall J, Cai S, Chehab FF. A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat 1995;5:333-8.
20. Goldblatt J, Creegan R, Edkins T, Landau LI, Ryan G, Walpole IR. Mutation analysis of Western Australian families affected by cystic fibrosis. Med J Aust 1995;162:12-5.
21. Audrezet MP, Costes B, Ghanem N, Fanen P, Verlingue C, Morin JF, et al. Screening for cystic fibrosis in dried blood spots of newborns. Mol Cell Probes 1993;7:497-502.
22. Ferec C, Verlingue C, Parent P, Morin JF, Codet JP, Rault G, et al. Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses. Hum Genet 1995;96:542-8.
23. Lu W, Han D-S, Yuan J, Andrieu J-M. Multi-target PCR analysis by capillary electrophoresis and laser-induced fluorescence. Nature 1994;368:269-71.
24. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnol 1996;14:1675-80.
25. Iitiä A, Liukkonen L, Siitari H. Simultaneous detection of two cystic fibrosis alleles using dual-label time-resolved fluorometry. Mol Cell Probes 1992;6:505-12.
26. Sjöroos M, Iitia A, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Bio-Techniques 1995;18:870-7.
27. Nørgaard-Pedersen B, Høgdall E, Iitiä A, Dahlén P, Vuust J. Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: an anonymous pilot study in Denmark. Screening 1993;2:1-11.